Catherine Guly

737 total citations
29 papers, 361 citations indexed

About

Catherine Guly is a scholar working on Ophthalmology, Rheumatology and Hematology. According to data from OpenAlex, Catherine Guly has authored 29 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Ophthalmology, 14 papers in Rheumatology and 13 papers in Hematology. Recurrent topics in Catherine Guly's work include Ocular Diseases and Behçet’s Syndrome (22 papers), Autoimmune and Inflammatory Disorders Research (13 papers) and Systemic Lupus Erythematosus Research (10 papers). Catherine Guly is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (22 papers), Autoimmune and Inflammatory Disorders Research (13 papers) and Systemic Lupus Erythematosus Research (10 papers). Catherine Guly collaborates with scholars based in United Kingdom, Australia and United States. Catherine Guly's co-authors include Athimalaipet V Ramanan, Andrew D. Dick, Richard Lee, Michael W. Beresford, Ashley P Jones, Ben Hardwick, Andrew McKay, Thomas Jaki, Ester Carreño and Matthew D. Smyth and has published in prestigious journals such as The Lancet, JAMA and Annals of the Rheumatic Diseases.

In The Last Decade

Catherine Guly

26 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Guly United Kingdom 10 274 188 166 43 42 29 361
V. Despert France 6 105 0.4× 99 0.5× 234 1.4× 12 0.3× 93 2.2× 14 363
Ida Orlando Italy 13 394 1.4× 62 0.3× 259 1.6× 109 2.5× 55 1.3× 22 516
F.Z. Alaoui Morocco 5 74 0.3× 230 1.2× 77 0.5× 39 0.9× 137 3.3× 24 368
Nicole Stuebiger Germany 13 403 1.5× 78 0.4× 160 1.0× 67 1.6× 21 0.5× 25 448
Florence Uettwiller France 9 33 0.1× 123 0.7× 54 0.3× 20 0.5× 55 1.3× 17 268
Suhan Günaştı Türkiye 7 85 0.3× 46 0.2× 125 0.8× 53 1.2× 11 0.3× 13 285
Julia García-Consuegra Spain 6 37 0.1× 84 0.4× 84 0.5× 111 2.6× 156 3.7× 7 315
Yüksel Süllü Türkiye 13 393 1.4× 27 0.1× 72 0.4× 34 0.8× 38 0.9× 35 472
P. Fanlo Spain 7 97 0.4× 24 0.1× 95 0.6× 66 1.5× 37 0.9× 37 188
Sandrine Meunier France 12 54 0.2× 346 1.8× 13 0.1× 19 0.4× 171 4.1× 45 578

Countries citing papers authored by Catherine Guly

Since Specialization
Citations

This map shows the geographic impact of Catherine Guly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Guly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Guly more than expected).

Fields of papers citing papers by Catherine Guly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Guly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Guly. The network helps show where Catherine Guly may publish in the future.

Co-authorship network of co-authors of Catherine Guly

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Guly. A scholar is included among the top collaborators of Catherine Guly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Guly. Catherine Guly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ramanan, Athimalaipet V, Catherine Guly, Gabriele Simonini, et al.. (2025). Effectiveness and Safety of Baricitinib for Juvenile Idiopathic Arthritis–Associated Uveitis or Chronic Anterior Antinuclear Antibody–Positive Uveitis. Arthritis Care & Research.
2.
Acharya, Nisha R., Athimalaipet V Ramanan, Catherine Guly, et al.. (2025). Stopping of adalimumab in juvenile idiopathic arthritis-associated uveitis (ADJUST): a multicentre, double-masked, randomised controlled trial. The Lancet. 405(10475). 303–313. 3 indexed citations
3.
Dick, Andrew D., Thomas Jaki, David S. Robertson, et al.. (2025). Bayesian trial of adalimumab versus secukinumab for children with juvenile idiopathic arthritis associated uveitis or chronic anterior uveitis. Pediatric Rheumatology. 23(1). 55–55. 1 indexed citations
4.
Kreps, Elke O., et al.. (2024). Long-Term Visual Outcome of Patients with Blau Syndrome. Ocular Immunology and Inflammation. 32(8). 1728–1732. 3 indexed citations
5.
Maccora, Ilaria, Gabriele Simonini, Catherine Guly, & Athimalaipet V Ramanan. (2024). Management of JIA associated uveitis. Best Practice & Research Clinical Rheumatology. 38(3). 101979–101979. 3 indexed citations
6.
Clarke, Sarah L. N., Panagiotis Maghsoudlou, Catherine Guly, Andrew D. Dick, & Athimalaipet V Ramanan. (2024). The management of adult and paediatric uveitis for rheumatologists. Nature Reviews Rheumatology. 20(12). 795–808.
7.
Ndosi, Mwidimi, Celia Almeida, Jill Dawson, et al.. (2023). Validation of a patient-reported outcome measure for giant cell arteritis. Lara D. Veeken. 63(1). 181–189. 3 indexed citations
8.
Guly, Catherine, et al.. (2022). Similarities in the histological mouse model of early herpes simplex retinopathy with punctate inner choroidopathy and Ebola virus disease retinopathy. European Journal of Ophthalmology. 33(3). NP148–NP149. 1 indexed citations
9.
10.
Ramanan, Athimalaipet V, Andrew D. Dick, Catherine Guly, et al.. (2020). Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial. The Lancet Rheumatology. 2(3). e135–e141. 76 indexed citations
11.
Horton, Sarah, Ashley P Jones, Catherine Guly, et al.. (2019). Adalimumab in Juvenile Idiopathic Arthritis–Associated Uveitis: 5-Year Follow-up of the Bristol Participants of the SYCAMORE Trial. American Journal of Ophthalmology. 207. 170–174. 36 indexed citations
12.
Guly, Catherine, et al.. (2019). Same but different? A thematic analysis on adalimumab biosimilar switching among patients with juvenile idiopathic arthritis. Pediatric Rheumatology. 17(1). 67–67. 11 indexed citations
13.
Ramanan, Athimalaipet V, et al.. (2018). Outcomes of non-infectious Paediatric uveitis in the era of biologic therapy. Pediatric Rheumatology. 16(1). 51–51. 54 indexed citations
14.
Ramanan, Athimalaipet V, Andrew D. Dick, Ashley P Jones, et al.. (2018). A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial). BMC Rheumatology. 2(1). 4–4. 23 indexed citations
15.
Salek, Sherveen, et al.. (2017). Uveitis and Juvenile Psoriatic Arthritis or Psoriasis. American Journal of Ophthalmology. 185. 68–74. 16 indexed citations
16.
Horton, Sarah J. & Catherine Guly. (2017). Prevention and treatment of age‐related macular degeneration. Prescriber. 28(1). 37–41. 2 indexed citations
17.
Dick, Andrew D., Richard Lee, Athimalaipet V Ramanan, et al.. (2015). Managing juvenile idiopathic arthritis–associated uveitis. Survey of Ophthalmology. 61(2). 197–210. 28 indexed citations
18.
Bennetto, Luke, Catherine Guly, I E Ormerod, & Gordon T. Plant. (2014). Eye drop neurology. Practical Neurology. 14(3). 145–151. 3 indexed citations
19.
Lowry, Lisa, et al.. (2014). Bilateral optic neuropathy associated with Castleman disease. British Journal of Haematology. 167(4). 439–439.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by V. Despert Breakdown of academic impact, for papers by Ida Orlando Breakdown of academic impact, for papers by F.Z. Alaoui Breakdown of academic impact, for papers by Nicole Stuebiger Breakdown of academic impact, for papers by Florence Uettwiller Breakdown of academic impact, for papers by Suhan Günaştı Breakdown of academic impact, for papers by Julia García-Consuegra Breakdown of academic impact, for papers by Yüksel Süllü Breakdown of academic impact, for papers by P. Fanlo Breakdown of academic impact, for papers by Sandrine Meunier
Rankless by CCL
2026